4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-027425
EVP, Research & CSO acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-16 | Exercise or conversion : show line 1 in the form | +3,500 | $1.53 | $5,355 | 91,700 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-16 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −3,500 | 314,495 | D |
Loading xslF345X03/doc4.xml…